Given that HF diet and NLRC4 affect gut permeability and microbiota homeostasis, therefore contributing to endotoxemia and endotoxemia-related inflammation [47,48], the investigation of NLRC4 activation in obesity appears to be intriguing as well, but few data are available right now [49,50]. The gene discussed is NLRC4; the disease is serum lipopolysaccharide activity.